Tag: TUBERCULOSIS

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly To reduce tuberculosis transmission, morbidity and mortality to such a level that tuberculosis is no longer a public health problem

    Neftaly To reduce tuberculosis transmission, morbidity and mortality to such a level that tuberculosis is no longer a public health problem

    Certainly! Here’s a strong and professional content draft for Neftaly focused on its vision and efforts “To reduce tuberculosis transmission, morbidity and mortality to such a level that tuberculosis is no longer a public health problem.”


    Neftaly: Ending Tuberculosis as a Public Health Threat

    Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, despite being preventable and curable. Millions of people fall ill every year, with the greatest burden affecting low-income and vulnerable populations. Neftaly is committed to changing that.

    Our mission is clear: to reduce TB transmission, illness, and death to such low levels that TB is no longer a public health problem.

    This vision aligns with the global goal to end the TB epidemic by 2030, as outlined in the WHO End TB Strategy and the Sustainable Development Goals (SDGs). Neftaly works in partnership with governments, civil society, healthcare providers, and communities to build strong, equitable, and sustainable TB responses.


    Our Strategic Focus Areas

    1. Early Detection and Timely Diagnosis

    We scale up access to accurate and rapid TB testing by:

    • Deploying molecular diagnostic tools like GeneXpert in high-burden settings
    • Training frontline health workers to identify TB symptoms and screen at-risk populations
    • Integrating TB screening with other health services, especially HIV, maternal health, and primary care

    2. Universal Access to Quality Treatment

    To break the chain of transmission and prevent drug resistance, we ensure that:

    • Every person diagnosed with TB receives free, effective treatment with full support
    • Multidrug-resistant TB (MDR-TB) cases are managed with second-line drugs and close follow-up
    • Treatment models are people-centered, promoting adherence and reducing stigma

    3. Preventing TB in Vulnerable Populations

    We prioritize prevention strategies, including:

    • TB preventive therapy (TPT) for high-risk groups such as people living with HIV and household contacts of TB patients
    • Strengthening infection control in healthcare facilities, schools, and workplaces
    • Promoting behavior change communication to raise awareness and encourage early care-seeking

    4. Community Engagement and Empowerment

    We believe communities are at the heart of TB elimination. Neftaly supports:

    • Community health worker networks to deliver DOT (directly observed therapy), health education, and follow-up care
    • Empowering TB survivors and advocates to reduce stigma and influence policy
    • Mobilizing local resources and leadership to sustain TB awareness and support efforts

    5. Health System Strengthening and Sustainability

    To make progress sustainable, we:

    • Support national TB programs in planning, monitoring, and financing TB services
    • Improve data collection and surveillance systems to track progress and respond quickly
    • Advocate for universal health coverage (UHC) so TB care is accessible to all, regardless of income or location

    Our Vision for Impact

    By reducing TB transmission, morbidity, and mortality, Neftaly envisions:

    • Fewer new TB infections each year through widespread prevention and public education
    • High treatment success rates, especially for drug-resistant TB
    • Dramatic declines in TB-related deaths, particularly among vulnerable populations
    • Stronger, more resilient health systems equipped to sustain TB control efforts long-term
  • Neftaly Tuberculosis – Namibia (01-Oct-2011-30-Sep-2013)

    Neftaly Tuberculosis – Namibia (01-Oct-2011-30-Sep-2013)

    Neftaly Tuberculosis Program – Namibia
    Project Duration: 01 October 2011 – 30 September 2013
    Project Title: Strengthening TB Control and Expanding Access to TB and MDR-TB Services in Namibia

    Background

    Namibia has long struggled with a high burden of tuberculosis, one of the leading causes of illness and death in the country. The dual epidemic of TB and HIV, combined with the rise in multidrug-resistant TB (MDR-TB), placed immense pressure on Namibia’s public health system. Many patients—especially those in remote regions and underserved communities—faced delays in diagnosis, limited access to treatment, and challenges in completing therapy.

    In response to this urgent public health need, Neftaly implemented a two-year TB control initiative in partnership with Namibia’s Ministry of Health and Social Services (MoHSS). The goal was to expand access to high-quality TB and MDR-TB services and to strengthen the capacity of the national TB program to deliver sustainable, patient-centered care.

    Program Objectives

    • Improve early detection and accurate diagnosis of TB and MDR-TB
    • Expand equitable access to high-quality treatment and care
    • Support effective TB/HIV collaborative activities
    • Build the capacity of healthcare workers and health facilities
    • Strengthen the surveillance and monitoring system for TB control

    Key Program Components

    1. TB and MDR-TB Case Detection

    • Introduced GeneXpert technology for rapid diagnosis of TB and rifampicin resistance in key districts
    • Trained laboratory staff and healthcare workers in sample collection, testing protocols, and quality assurance
    • Deployed mobile outreach teams to increase TB screening in high-burden and hard-to-reach areas

    2. Access to Treatment and Adherence Support

    • Strengthened directly observed treatment (DOT) services in health facilities and communities
    • Supported the rollout of second-line treatment for MDR-TB patients, including clinical monitoring and psychosocial support
    • Improved treatment adherence through community-based care models and patient follow-up systems

    3. Integrated TB/HIV Services

    • Promoted routine HIV testing and counseling for all TB patients
    • Provided co-trimoxazole prophylaxis and ART for eligible TB/HIV co-infected patients
    • Facilitated joint TB/HIV training for service providers to ensure continuity of care

    4. Health Workforce and Facility Strengthening

    • Trained over 800 healthcare providers in TB case management, drug-resistant TB protocols, and infection control
    • Supported health facilities with guidelines, treatment algorithms, and monitoring tools
    • Improved infrastructure in selected DOT centers and MDR-TB treatment units

    5. Monitoring, Evaluation, and Data Management

    • Strengthened national and district-level TB surveillance and reporting systems
    • Introduced digital case-tracking tools to monitor treatment outcomes and patient retention
    • Supported regular data reviews and operational research to inform program improvements

    Key Achievements (2011–2013)

    • GeneXpert machines deployed in 7 districts, resulting in faster diagnosis and earlier treatment initiation
    • Case detection rates improved by over 20% in target regions
    • Treatment success rates exceeded 85% in supported sites
    • More than 1,500 patients with MDR-TB enrolled in care with structured follow-up and support
    • TB/HIV integration expanded, with over 90% of TB patients tested for HIV
    • Enhanced national capacity for TB program planning, supervision, and evaluation

    Conclusion

    Neftaly’s TB program in Namibia demonstrated that targeted investments in diagnostics, healthcare workforce development, and community engagement can significantly improve TB outcomes. The program strengthened Namibia’s ability to detect, treat, and manage TB and MDR-TB, while aligning efforts with broader health system goals and global TB strategies.

  • Neftaly Tuberculosis – Namibia (01-Jun-2006-31-May-2011)

    Neftaly Tuberculosis – Namibia (01-Jun-2006-31-May-2011)

    Neftaly Tuberculosis Program – Namibia
    Project Duration: 01 June 2006 – 31 May 2011
    Project Title: Scaling Up Tuberculosis Prevention, Diagnosis, and Treatment in High-Burden Regions of Namibia

    Background

    Namibia has one of the highest tuberculosis (TB) incidence rates in the world, exacerbated by its high HIV prevalence. During the mid-2000s, the country faced significant challenges in TB case detection, treatment adherence, and rising cases of drug-resistant TB (DR-TB). Health systems were under strain, particularly in rural and underserved regions, and many patients lacked access to timely diagnosis and care.

    In response to this urgent public health need, Neftaly launched a five-year initiative in partnership with the Ministry of Health and Social Services (MoHSS) to support Namibia’s National TB and Leprosy Programme (NTLP). The program focused on expanding TB control services, building health system capacity, and integrating TB/HIV interventions.

    Program Objectives

    • Increase TB case detection and improve diagnostic accuracy
    • Enhance treatment success rates and reduce loss to follow-up
    • Strengthen TB/HIV collaborative services
    • Build capacity of health workers, laboratories, and community health systems
    • Lay the foundation for the management of multidrug-resistant TB (MDR-TB)

    Strategic Interventions

    1. Case Detection and Laboratory Strengthening

    • Expanded access to TB testing through microscopy centers and trained lab technicians across all 13 regions
    • Established quality assurance systems for sputum smear microscopy
    • Improved specimen transport systems to reduce turnaround time for results

    2. Access to Treatment and DOT Implementation

    • Scaled up the Directly Observed Treatment, Short-course (DOTS) strategy at facility and community levels
    • Trained healthcare workers and community volunteers to support treatment adherence and follow-up
    • Supplied first-line TB medications and ensured regular monitoring for side effects and outcomes

    3. TB/HIV Collaborative Activities

    • Integrated TB screening and HIV testing in all TB clinics
    • Provided co-trimoxazole prophylaxis and antiretroviral therapy (ART) to co-infected patients
    • Supported joint TB/HIV training programs for frontline health workers

    4. Community Engagement and Health Education

    • Conducted widespread awareness campaigns to reduce stigma and promote early care-seeking behavior
    • Engaged traditional leaders, churches, and civil society organizations in TB prevention messaging
    • Supported patient support groups and peer-led education initiatives

    5. Health System and Capacity Building

    • Trained over 1,500 health workers in TB case management, infection control, and TB/HIV integration
    • Strengthened program supervision, data management, and reporting through district and regional TB coordinators
    • Supported the development of TB policy guidelines and national strategic frameworks

    Results and Impact (2006–2011)

    • TB case detection improved by over 30% in supported regions
    • Treatment success rates exceeded 80%, surpassing national targets in several districts
    • Over 90% of TB patients were tested for HIV, improving linkage to care
    • Community DOTS coverage expanded to more than 80% of rural health districts
    • National capacity for MDR-TB preparedness and response was significantly enhanced
    • Strengthened laboratory network and human resources across the TB care cascade

    Conclusion

    Neftaly’s five-year TB intervention in Namibia was instrumental in expanding equitable access to TB services, improving patient outcomes, and laying a strong foundation for future TB and DR-TB response efforts. By investing in communities, health systems, and frontline workers, the program helped reduce the TB burden and aligned Namibia’s efforts with global Stop TB Partnership goals.

  • Neftaly Tuberculosis – Nepal (16-Nov-2008-15-Jul-2010)

    Neftaly Tuberculosis – Nepal (16-Nov-2008-15-Jul-2010)

    Neftaly Tuberculosis Project – Nepal

    Duration: 16 November 2008 – 15 July 2010

    Overview

    The Neftaly Tuberculosis (TB) project in Nepal was a targeted initiative focused on enhancing TB control and management within high-risk communities from November 2008 to July 2010. This program aimed to strengthen local healthcare capacities, increase community awareness, and improve TB case detection and treatment adherence.

    Objectives

    • To improve early detection and diagnosis of tuberculosis cases through community-based screening and referral systems.
    • To enhance treatment success rates by providing patient-centered support and follow-up mechanisms.
    • To raise awareness about TB prevention, symptoms, and treatment options among vulnerable populations.
    • To build capacity among healthcare workers and volunteers on the latest TB control protocols.

    Activities

    • Conducted community mobilization and education campaigns to reduce stigma and increase knowledge of TB.
    • Trained healthcare providers and community health volunteers on TB identification, patient counseling, and DOTS (Directly Observed Treatment, Short-course) strategies.
    • Facilitated active case finding through regular outreach visits and sputum collection camps.
    • Established a monitoring system to track treatment progress and ensure adherence to prescribed medication regimens.
    • Collaborated with local government health units to integrate TB services into routine health care delivery.

    Achievements

    • Significant increase in TB case detection rates within target districts.
    • Improved treatment adherence leading to higher cure rates and reduced default rates.
    • Strengthened community engagement contributed to reduced stigma surrounding TB patients.
    • Enhanced skills and knowledge of local health workers, ensuring sustainability of TB control efforts beyond the project period.

    Challenges

    • Geographic and logistic barriers limited access to some remote populations.
    • Cultural misconceptions about TB required ongoing efforts to change community perceptions.
    • Resource constraints affected scale-up potential in certain areas.

    Conclusion

    The Neftaly Tuberculosis project in Nepal successfully contributed to improved TB control by combining community involvement, healthcare provider training, and system strengthening. The lessons learned and frameworks developed during this period continue to inform TB prevention and management efforts in Nepal.